Inventor · disambiguated record
Samir N. Khleif
Also filed as: KHLEIF SAMIR · KHLEIF SAMIR N
23 granted patents·30 pending applications·70 citations·filing 2001–2025
94Inventor score
Files withUNIV RES INST INC AUGUSTA25GEORGIAMUNE INC6GEORGIAMUNE LLC4PDS BIOTECHNOLOGY CORP4US HEALTH4
Top patents by PatentIndex Score
53 records- 0194US10980878B2Methods and compositions for modulating Akt3 activityUNIV RES INST INC AUGUSTA·Filed 2020·Granted Apr 20, 2021·3 cites·11 claims
- 0294US10828364B2Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2019·Granted Nov 10, 2020·8 cites·19 claims
- 0394US10588966B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2019·Granted Mar 17, 2020·5 cites·14 claims
- 0493US11780921B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2021·Granted Oct 10, 2023·2 cites·15 claims
- 0593US10342868B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2017·Granted Jul 9, 2019·6 cites·12 claims
- 0692US11021540B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2018·Granted Jun 1, 2021·4 cites·12 claims
- 0792US10525049B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2019·Granted Jan 7, 2020·5 cites·8 claims
- 0892US10292978B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2017·Granted May 21, 2019·6 cites·9 claims
- 0991US12201685B2Methods of modulating immune responses with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Jan 21, 2025·2 cites·18 claims
- 1090US10159731B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2018·Granted Dec 25, 2018·6 cites·2 claims
- 1189US11013735B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2019·Granted May 25, 2021·2 cites·7 claims
- 1288US10286064B2Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2013·Granted May 14, 2019·9 cites·3 claims
- 1388US9707278B2Methods of modulating immune responses by modifying Akt3 bioactivityAUGUSTA UNIV RES INST INC·Filed 2015·Granted Jul 18, 2017·4 cites·6 claims
- 1486US7507538B2Human papilloma virus immunoreactive peptidesUS HEALTH·Filed 2007·Granted Mar 24, 2009·3 cites·15 claims
- 1584US12209127B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2023·Granted Jan 28, 2025·0 cites·21 claims
- 1683US11291719B2Methods and compositions for modulating Akt3UNIV RES INST INC AUGUSTA·Filed 2020·Granted Apr 5, 2022·1 cites·16 claims
- 1782US11957673B2Specific AKT3 activator and uses thereofUNIV RES INST INC AUGUSTA·Filed 2018·Granted Apr 16, 2024·1 cites·29 claims
- 1879US2024316190A1Compositions and methods for selectively modulating tregsUNIV RES INST INC AUGUSTA·Filed 2023·Application pending·0 cites
- 1977US7189513B2Human papilloma virus immunoreactive peptidesUS HEALTH·Filed 2002·Granted Mar 13, 2007·3 cites·6 claims
- 2076US2025186582A1Methods for detecting and reversing immune therapy resistanceUNIV RES INST INC AUGUSTA·Filed 2024·Application pending·0 cites
- 2175US12168687B2Antibodies to programmed cell death protein 1 that are PD-1 agonistsGEORGIAMUNE INC·Filed 2024·Granted Dec 17, 2024·0 cites·30 claims
- 2275US2025009735A1Specific akt3 activator and uses thereofUNIV RES INST INC AUGUSTA·Filed 2024·Application pending·0 cites
- 2372US2025154256A1Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2025·Application pending·0 cites
- 2472US2021346496A1Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 2571US2025136692A1Antibodies to programmed cell death protein 1 that are pd-1 agonistsGEORGIAMUNE INC·Filed 2024·Application pending·0 cites
- 2666US2021196817A1Compositions and Methods for Selectively Modulating TregsUNIV RES INST INC AUGUSTA·Filed 2020·Application pending·0 cites
- 2763US12048745B2Methods for detecting and reversing immune therapy resistanceUNIV RES INST INC AUGUSTA·Filed 2019·Granted Jul 30, 2024·0 cites·23 claims
- 2863US2021348125A1Induced stem memory t cells and methods of use thereofUNIV RES INST INC AUGUSTA·Filed 2021·Application pending·0 cites
- 2959US8378071B2Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesisUS HEALTH·Filed 2009·Granted Feb 19, 2013·0 cites·10 claims
- 3057US2023323296A1Stem cell-like memory t cells and uses thereofUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 3157US2025051419A1Polypeptide modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 3257US2016051669A1Compositions and methods for selectively modulating tregsGEORGIA REGENTS UNIVERSITY RES INST INC·Filed 2015·Application pending·0 cites
- 3356US2023201188A1Compositions and methods for treating leukemiaUNIV RES INST INC AUGUSTA·Filed 2021·Application pending·0 cites
- 3456US2025074905A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 3556US2018153898A1Compositions for modulating pd-1 signal transductionUNIV RES INST INC AUGUSTA·Filed 2017·Application pending·0 cites
- 3656US2023295114A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3755US2023183226A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3855US2023219927A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3955US2020147091A1Compositions for modulating pd-1 signal transductionUNIV RES INST INC AUGUSTA·Filed 2020·Application pending·0 cites
- 4055US2019127694A1Induced Stem Memory T-Cells and Methods of Use ThereofUNIV RES INST INC AUGUSTA·Filed 2018·Application pending·0 cites
- 4154US2025002511A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 4254US2023181563A1Akt3 modulators and methods of use thereofGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 4349US7691579B2Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogenUS HEALTH·Filed 2006·Granted Apr 6, 2010·0 cites·20 claims
- 4449US2024228457A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2021·Application pending·0 cites
- 4545US2006234941A1Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesisGOV OF THE USA AS REPRESENTED·Filed 2006·Application pending·0 cites
- 4644US2002044948A1Methods and compositions for co-stimulation of immunological responses to peptide antigensFiled 2001·Application pending·0 cites
- 4744US2017216355A1Methods and Compositions for Enhancing T Cell Function and SurvivalAUGUSTA UNIV RES INST INC·Filed 2017·Application pending·0 cites
- 4843US2017368157A1Combination Of Listeria-Based Vaccine With Anti-OX40 Or Anti-GITR AntibodiesADVAXIS INC·Filed 2015·Application pending·0 cites
- 4942US2018271870A1Compositions and Methods for Immune TherapyUNIV RES INST INC AUGUSTA·Filed 2015·Application pending·0 cites
- 5041US2018064765A1Listeria-based immunogenic compositions for eliciting anti-tumor responsesADVAXIS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →